Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-28

Clinical Trial Update: Targeting Endoplasmic Reticulum Stress in Human Hypertension [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial is evaluating targeting endoplasmic reticulum stress as a treatment for hypertension. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Texas Health Science Center | Conditions: Hypertension | Phase 1, Phase 2 | Status: RECRUITING